New Guidelines Reveal Doctors Will Not Recommend Low-Dose Aspirin to Healthy People

Low-dose aspirin has been used from a long period to reduce the chances of heart problems like heart attack or stroke. From the past many decades, health experts recommended taking a small aspirin to men over 50 and women over 50. They surmised it decreases the chance to get a heart attack. But the American College of Cardiology and the American Heart Association dismissed that famous remedy on Sunday. Aspirin can regulate and prevent platelets from clotting together. It also avoids blockages in arteries which may lead to heart stroke or attack. But the ACC and AHA recommend continuing the pill only under a doctor’s supervision. The agencies suggest people consume a low-dose aspirin only if they previously had a cardiac issue.

The move arrives after a massive international study discovered that eating a little aspirin for an extended period may be harmful. Those pills do not offer any benefit for older people who do not have a case history of heart issues. People without heart disease who take aspirin daily may decrease the risk of a heart attack or stroke. But the new study reveals those people may encounter internal bleeding. According to the new guidelines, doctors may prescribe aspirin for some older high-risk patients. It may include people having high cholesterol and high blood sugars.

Dr. Roger Blumenthal, an American Heart Association volunteer expert, said the science has advanced. Dr. Roger is a member of the guidelines writing committee and suggests taking aspirin every day is no longer self-activating for people who never had a cardiac arrest. According to the health association, nearly 80% of all cardiovascular diseases can be prevented by making some changes in the way of living. Health experts suggest a regular physical activity and following plant-based diets which could help people to stay healthy and fit. Aspirin can be life-saving for the people who have had a stroke, heart attack, or any other heart issues. So the treatment entirely depends on the case history of a patient and the situation.

Show More

Jason Amato

Jason was appointed to a three-year term at in September 2015. Later he was continued as the chief editor of the publication. In his role, Jason serves as the public's representative to He is responsible for bringing transparency to matters of journalism and journalism ethics. receives tens and thousands of inquiries annually and the Jason responds to significant queries, comments, and criticisms. Jason has a decade of experience taking an objective at the media industry and this experience has helped her is expertizing business and health sectors. So, when it's about business and health news, Jason is the go-to guy at

Leave a Reply

Your email address will not be published. Required fields are marked *